|
CPNE3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
3.574918139293E-14 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
2.968400E-01 |
| Stage1-vs-Stage3 |
5.816000E-01 |
| Stage1-vs-Stage4 |
1.156580E-01 |
| Stage2-vs-Stage3 |
1.903570E-01 |
| Stage2-vs-Stage4 |
4.772200E-02 |
| Stage3-vs-Stage4 |
2.998400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.71009872929062E-11 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
3.917400E-01 |
| Caucasian-vs-Asian |
5.148800E-01 |
| AfricanAmerican-vs-Asian |
2.565000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
4.614400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
2.52479999995892E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.442000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.717800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.659200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.562400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.314800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.930400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.870000E-01 |
| Classical-VS-Follicular |
2.205200E-01 |
| Classical-VS-Other |
1.306410E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
6.133800E-02 |
| Tall-VS-Other |
2.882400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.229630E-01 |
| Follicular-VS-Normal |
1.62447832963153E-12 |
| Other-VS-Normal |
1.5373999995294E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.273420E-01 |
|
|
